Cottrell ML - Search Results

1

Safety and Pharmacokinetics of a Tenofovir Alafenamide Fumarate-Emtricitabine based Oral Antiretroviral Regimen for Prevention of HIV Acquisition in Women: A Randomized Controlled Trial.

Thurman AR, Schwartz JL, Cottrell ML, Brache V, Chen BA, Cochón L, Ju S, McGowan I, Rooney JF, McCallister S, Doncel GF. Thurman AR, et al. Among authors: cottrell ml. EClinicalMedicine. 2021 May 23;36:100893. doi: 10.1016/j.eclinm.2021.100893. eCollection 2021 Jun. EClinicalMedicine. 2021. PMID: 34041459 Free PMC article.

2

Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues.

Cottrell ML, Garrett KL, Prince HMA, Sykes C, Schauer A, Emerson CW, Peery A, Rooney JF, McCallister S, Gay C, Kashuba ADM. Cottrell ML, et al. J Antimicrob Chemother. 2017 Jun 1;72(6):1731-1740. doi: 10.1093/jac/dkx064. J Antimicrob Chemother. 2017. PMID: 28369415 Free PMC article. Clinical Trial.

3

Differences in Local and Systemic TFV PK Among Premenopausal Versus Postmenopausal Women Exposed to TFV 1% Vaginal Gel.

Thurman AR, Chandra N, Yousefieh N, Kimble T, Anderson SM, Cottrell M, Sykes C, Kashuba A, Schwartz JL, Doncel GF. Thurman AR, et al. J Acquir Immune Defic Syndr. 2018 May 1;78(1):82-92. doi: 10.1097/QAI.0000000000001648. J Acquir Immune Defic Syndr. 2018. PMID: 29424790 Free PMC article.

4

Genital Mucosal Drug Concentrations and anti-HIV Activity in Tenofovir-Based PrEP Products: Intravaginal Ring vs. Oral Administration.

Ouattara LA, Thurman AR, Jacot TA, Cottrell M, Sykes C, Blake K, Fang X, Ju S, Vann NC, Schwartz J, Doncel GF. Ouattara LA, et al. J Acquir Immune Defic Syndr. 2022 Jan 1;89(1):87-97. doi: 10.1097/QAI.0000000000002820. J Acquir Immune Defic Syndr. 2022. PMID: 34878438 Free PMC article. Clinical Trial.

5

Effect of HIV infection and menopause status on raltegravir pharmacokinetics in the blood and genital tract.

Cottrell ML, Patterson KB, Prince HM, Jones A, White N, Wang R, Kashuba AD. Cottrell ML, et al. Antivir Ther. 2015;20(8):795-803. doi: 10.3851/IMP2968. Epub 2015 Jun 3. Antivir Ther. 2015. PMID: 26040011 Free PMC article. Clinical Trial.

6

Tenofovir/emtricitabine metabolites and endogenous nucleotide exposures are associated with p16(INK4a) expression in subjects on combination therapy.

Dumond JB, Francis O, Cottrell M, Trezza C, Prince HM, Mollan K, Sykes C, Torrice C, White N, Malone S, Wang R, Van Dam C, Patterson KB, Hudgens MG, Sharpless NE, Forrest A. Dumond JB, et al. Antivir Ther. 2016;21(5):441-5. doi: 10.3851/IMP3017. Epub 2016 Jan 5. Antivir Ther. 2016. PMID: 26731175 Free PMC article.

7

p16^INK4a , a Senescence Marker, Influences Tenofovir/Emtricitabine Metabolite Disposition in HIV-Infected Subjects.

Dumond JB, Collins JW, Cottrell ML, Trezza CR, Prince H, Sykes C, Torrice C, White N, Malone S, Wang R, Patterson KB, Sharpless NE, Forrest A. Dumond JB, et al. Among authors: cottrell ml. CPT Pharmacometrics Syst Pharmacol. 2017 Feb;6(2):120-127. doi: 10.1002/psp4.12150. Epub 2016 Dec 26. CPT Pharmacometrics Syst Pharmacol. 2017. PMID: 28019088 Free PMC article. Clinical Trial.

8

Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection.

Kayes T, Crane H, Symonds A, Dumond J, Cottrell M, Di Girolamo J, Manandhar S, Lim TH, Gane E, Kashuba A, Levy MT. Kayes T, et al. Aliment Pharmacol Ther. 2022 Aug;56(3):510-518. doi: 10.1111/apt.17040. Epub 2022 May 22. Aliment Pharmacol Ther. 2022. PMID: 35599363

9

Doravirine Concentrations and Human Immunodeficiency Virus Type 1 RNA in the Genital Fluids of Virologically Suppressed Adults Switching to Doravirine Plus Emtricitabine/Tenofovir Alafenamide.

Scévola S, Imaz A, Cottrell ML, Niubo J, Van Horne B, Tiraboschi J, Saumoy M, Morenilla S, Soriano I, Kashuba ADM, Podzamczer D. Scévola S, et al. Among authors: cottrell ml. Clin Infect Dis. 2022 Nov 30;75(11):2012-2015. doi: 10.1093/cid/ciac410. Clin Infect Dis. 2022. PMID: 35616112

10

A multicompartment population PK model to predict tenofovir and emtricitabine mucosal tissue concentrations for HIV prevention.

Leung E, Cottrell ML, Sykes C, White N, Kashuba ADM, Dumond JB. Leung E, et al. Among authors: cottrell ml. CPT Pharmacometrics Syst Pharmacol. 2023 Dec;12(12):1922-1930. doi: 10.1002/psp4.13042. Epub 2023 Oct 9. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 37814498 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page